Related Experiment Video
Updated: Aug 6, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Association between fibrinogen and cognitive impairment in patients with ischemic cerebrovascular disease
Insights
Elevated fibrinogen levels are linked to cognitive impairment in ischemic cerebrovascular disease (ICVD) patients. Higher fibrinogen correlates with poorer global and executive function, and reduced white matter volume.
Area of Science:
- Neurology
- Neuroscience
- Cardiovascular Research
Background:
- Fibrinogen is a potential risk factor for vascular dementia (VaD).
- The relationship between fibrinogen and cognitive function in ischemic cerebrovascular disease (ICVD) patients requires further investigation.
Purpose of the Study:
- To examine the association between fibrinogen levels and cognitive impairment in ICVD patients.
- To investigate the role of white matter hyperintensities (WMH) and brain atrophy in this association.
Main Methods:
- A case-control study involving ICVD patients.
- Cognitive function assessed using the Montreal Cognitive Assessment.
- Brain magnetic resonance imaging (MRI) used to quantify WMH and brain atrophy.
- Conditional logistic regression and generalized additive models employed to analyze associations.
Main Results:
- Increased risk of cognitive impairment with higher fibrinogen levels (AOR = 1.92).
- Fibrinogen levels > 4 g/L significantly increased cognitive impairment risk (AOR = 5.72).
- Negative correlations observed between fibrinogen and global cognitive function (rs = -0.235), visuospatial/executive function (rs = -0.251), and normal-appearing white matter (NAWM) volume (rs = -0.282).
Conclusions:
- Fibrinogen is significantly associated with cognitive impairment in ICVD patients.
- Fibrinogen negatively impacts global cognitive function, visuospatial/executive function, and NAWM volume.
- Further research into the mechanistic pathways linking fibrinogen and cognitive decline is warranted.
Objectives:
Fibrinogen has been reported as a potential risk factor for vascular dementia (VaD). However, the association between fibrinogen and cognition in patients with ischemic cerebrovascular disease (ICVD) has not been studied adequately. We aimed to examine the association of fibrinogen with cognitive impairment among patients with ICVD and to test whether white matter hyperintensities (WMH) and brain atrophy play a role under the association.
Methods:
In this case-control study, ICVD patients were recruited from the Neurology Department. Cognitive function was assessed using the Montreal Cognitive Assessment. WMH and brain atrophy were quantified by brain magnetic resonance imaging (MRI). The associations of fibrinogen with cognition and MRI markers were investigated by conditional logistic regression models and generalized additive models.
Results:
The risk of cognitive impairment increased with each unit increase in fibrinogen (AOR = 1.92, 95 % CI = 1.06 - 3.48). Individuals with fibrinogen levels > 4 g/L presented a substantially higher risk of cognitive impairment than those with fibrinogen levels of 2-4 g/L (AOR = 5.72, 95 % CI = 1.22- 26.82). Fibrinogen was negatively correlated with global cognitive function (rs = -0.235) and visuospatial/executive function (rs = -0.251). A negative correlation between fibrinogen and normal-appearing white matter (NAWM) volume was observed (rs = -0.282).
Conclusions:
Fibrinogen is associated with cognitive impairment among patients with ICVD, and significantly negatively impacts global cognitive function and visuospatial/executive function. Furthermore, the negative correlation between fibrinogen and NAWM volume supports further exploration of potential mechanistic paths.
Related Concept Videos
The Blood-brain Barrier
Photoreceptors and Visual Pathways
Prosopagnosia
Diabetic Retinopathy
Ischemic Stroke ll: Pathophysiology
Dementia l: Introduction

